Day 1 Subscription
By the end of Day 1, the Corona Remedies IPO had been subscribed 0.62 times, according to the available data. This subscription rate reflects the initial
interest from investors during the first day of the IPO. The rate is a crucial indicator, setting the tone for the overall subscription status. It helps in assessing the demand and investment interest for the IPO. This will also give an early idea about how successful the IPO might be, and whether it could be a potential investment option.
Day 2 Momentum
The subscription figures by the close of Day 2 provided a different perspective, with the issue being bid 9.96 times. This indicates a significant increase in investor interest compared to Day 1. This significant jump signifies a growing confidence in the IPO. Moreover, such a high subscription rate often suggests that the IPO is well-received in the market. This increase might also be influenced by various factors, including market sentiment, company performance, and the overall economic climate.
GMP and Listing
The Grey Market Premium (GMP) plays a crucial role in shaping expectations for the IPO's listing. The GMP, which is the premium at which the IPO shares are traded unofficially before listing, provides insights into investor sentiment. A high GMP generally indicates strong investor confidence and suggests a potential positive listing. While GMP is not a guaranteed indicator, it can provide valuable information about how the IPO might perform. A strong GMP would then typically suggest a positive outlook for the stock's performance after its official listing on the stock exchanges.
